1. Abraham, J., 1994: Negotiation and Accomodation in Expert Medical Risk Assessment and Regulation: An Institutional Analysis of the Benoxaprofen Case, in: Policy Sciences 27: 53–76.
2. Abraham, J., 1995: Science, Politics and the Pharmaceutical Industry: Controversy and Bias in Drug Regulation, London/New York, UCL Press.
3. Andersson, F., 1992: The Drug Lag Issue: The Debate Seen from an International Perspective, in: International Journal of Health Services 22: 53–72.
4. Andrew, M., JOldal, B., Tomson, G., 1995: Norway’s National Drug Policy: Its Evolution and Lessons for the Future, in: Development Dialogue 1: 25–53.
5. Annas, G.J., 1989: Faith (Healing), Hope and Charity at the FDA: The Politics of AIDS Drug Trials, in: Villanova Law Review 34: 771–797.